Patents by Inventor Sharad B. Murdande

Sharad B. Murdande has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
    Patent number: 6962931
    Abstract: CETP Inhibitors have improved solubility and bioavailability in a lipophilic vehicle comprising a digestible oil, a lipophilic solvent, or a surfactant. Preferred such compositions are self-emulsifying or self-microemulsifying, and comprise 1. a CETP inhibitor; 2. a cosolvent; 3. a surfactant having an HLB of 1 to 8; 4. a surfactant having an HLB of over 8 to 20; and 5. optionally, a digestible oil.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: November 8, 2005
    Assignee: Pfizer Inc.
    Inventors: Michael J. Gumkowski, Lombardo Franco, Sharad B. Murdande, Michael E. Perlman
  • Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
    Publication number: 20030022944
    Abstract: CETP Inhibitors have improved solubility and bioavailability in a lipophilic vehicle comprising a digestible oil, a lipophilic solvent, or a surfactant.
    Type: Application
    Filed: June 19, 2002
    Publication date: January 30, 2003
    Inventors: Michael J. Gumkowski, Lombardo Franco, Sharad B. Murdande, Michael E. Perlman
  • Epidural administration of therapeutic compounds with sustained rate of release
    Patent number: 6428529
    Abstract: A drug delivery system provides sustained-release delivery of therapeutic biologically active compounds administered epidurally. In the preferred embodiment the biologically active compound is an opioid, which is encapsulated within the non-concentric internal aqueous chambers or bilayers of multivesicular liposomes. The opioid is released over an extended period of time when the liposomes are introduced epidurally as a single dose for sustained analgesia.
    Type: Grant
    Filed: September 16, 1997
    Date of Patent: August 6, 2002
    Assignee: SkyePharma Inc.
    Inventors: Andres Gruber, Sharad B. Murdande, Taehee Kim, Sinil Kim
  • EPIDURAL ADMINISTRATION OF THERAPEUTIC COMPOUNDS WITH SUSTAINED RATE OF RELEASE
    Publication number: 20020065506
    Abstract: A drug delivery system provides sustained-release delivery of therapeutic biologically active compounds administered epidurally. In the preferred embodiment the biologically active compound is an opioid, which is encapsulated within the non-concentric internal aqueous chambers or bilayers of multivesicular liposomes. The opioid is released over an extended period of time when the liposomes are introduced epidurally as a single dose for sustained analgesia.
    Type: Application
    Filed: September 16, 1997
    Publication date: May 30, 2002
    Applicant: SkyePharma, Inc.
    Inventors: ANDRAS GRUBER, SHARAD B. MURDANDE, TAEHEE KIM, SINIL KIM
  • Epidural administration of therapeutic compounds with sustained rate of release
    Patent number: 5931809
    Abstract: A drug delivery system provides sustained-release delivery of therapeutic biologically active compounds administered epidurally. In the preferred embodiment the biologically active compound is an opioid, which is encapsulated within the non-concentric internal aqueous chambers or bilayers of multivesicular liposomes. The opioid is released over an extended period of time when the liposomes are introduced epidurally as a single dose for sustained analgesia.
    Type: Grant
    Filed: July 14, 1995
    Date of Patent: August 3, 1999
    Assignee: Depotech Corporation
    Inventors: Andres Gruber, Sharad B. Murdande, Taehee Kim, Sinil Kim